Thursday, February 23, 2017 8:03:39 AM
Dental Analogy (CYDY)
A long while ago I'm sitting in a chair in my Dentist's office when he hands be a toothbrush. He tells me that this brush is superior to any brush on the market. I asked why, and be gave me a rather long answer that sounded reasonable but I can't remember the rationale.
So, I said "why don't you take it to a major toothbrush company and try to make a deal"?
He said "I did" and I asked him what happened.
Here's the short form:
He said he went to XYZ Co. and met with the CEO who was flanked on both sides by an Engineer. After about 45 minutes they asked him if he would wait outside for a short while. He did and a few minutes later he was recalled.
The CEO said "you are right, your brush is more effective than any of ours........ but we can't make a deal"..The dentist asked why and was told "we have too much of an investment in our brushes".
Depending on one's perspective that answer makes sense or doesn't make sense. Doesn't matter. What might matter is whether this analogy describes GILD today.
A long while ago I'm sitting in a chair in my Dentist's office when he hands be a toothbrush. He tells me that this brush is superior to any brush on the market. I asked why, and be gave me a rather long answer that sounded reasonable but I can't remember the rationale.
So, I said "why don't you take it to a major toothbrush company and try to make a deal"?
He said "I did" and I asked him what happened.
Here's the short form:
He said he went to XYZ Co. and met with the CEO who was flanked on both sides by an Engineer. After about 45 minutes they asked him if he would wait outside for a short while. He did and a few minutes later he was recalled.
The CEO said "you are right, your brush is more effective than any of ours........ but we can't make a deal"..The dentist asked why and was told "we have too much of an investment in our brushes".
Depending on one's perspective that answer makes sense or doesn't make sense. Doesn't matter. What might matter is whether this analogy describes GILD today.
Recent CYDY News
- CytoDyn Completes Enrollment in Phase 2 Metastatic Colorectal Cancer Study • GlobeNewswire Inc. • 04/21/2026 08:10:00 PM
- CytoDyn Presents New Leronlimab Data in Metastatic Triple-Negative Breast Cancer at AACR Annual Meeting 2026 • GlobeNewswire Inc. • 04/20/2026 12:30:00 PM
- CytoDyn to Present at the AACR Annual Meeting 2026 • GlobeNewswire Inc. • 04/14/2026 12:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 04/08/2026 09:15:18 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 04/08/2026 12:30:28 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/25/2026 09:16:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:24:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:23:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:22:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:21:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:20:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:20:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/24/2026 09:15:24 PM
- CytoDyn Presents at AACR Special Conference in Cancer Research: Brain Cancer • GlobeNewswire Inc. • 03/24/2026 12:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/09/2026 09:15:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2026 01:35:02 PM
- CytoDyn Closes $17.5 Million Financing to Fund Continued Development of Leronlimab • GlobeNewswire Inc. • 03/05/2026 01:30:00 PM
- CytoDyn Presents Novel CCR5 Inhibition Mechanisms and Long-Term Survival Signals for Leronlimab in Metastatic Breast Cancer at AACR Immuno-Oncology Conference • GlobeNewswire Inc. • 02/20/2026 01:30:00 PM
- CytoDyn Announces Funding and Initiation of Expanded Access Program for Patients with Triple-negative Breast Cancer • GlobeNewswire Inc. • 01/27/2026 01:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/09/2026 10:15:22 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/09/2026 01:30:45 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 12/22/2025 10:15:23 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 12/17/2025 05:15:14 AM
- December 2025 Letter to Shareholders • GlobeNewswire Inc. • 12/16/2025 01:30:00 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 12/10/2025 10:16:32 PM
